<DOC>
	<DOCNO>NCT00003654</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , blue dye image identify sentinel lymph node , may improve ability detect extent disease help plan effective surgery remove breast tumor . PURPOSE : Diagnostic trial study effectiveness blue dye image procedure identify sentinel lymph node arm woman stage I stage II breast cancer .</brief_summary>
	<brief_title>Diagnostic Study Identify Sentinel Lymph Nodes Women With Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether concept sentinel lymph node within axillary nodal basin valid staging breast cancer . II . Determine sensitivity combine method identification sentinel lymph nodes patent blue V dye gamma probe detection woman . OUTLINE : Patients receive patent blue V dye injection peritumorally prior surgery . Preoperative lymphoscintigraphy perform use technetium Tc 99 sulfur rhenium colloid inject around tumor associate intraoperative gamma probe detection . Nonpalpable tumor receive localize injection use stereotactic injection technique . Patients undergo standard axillary ( level I II ) lymph node dissection . PROJECTED ACCRUAL : A total 200 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Technetium Tc 99m Sulfur Colloid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven stage I IIA invasive breast cancer T0 , T1 , T2 ( great 3 cm ) , N0 Noninflammatory Nonmetastatic No ductal carcinoma situ Eligible breastconserving surgery Hormone receptor status : Positive negative PATIENT CHARACTERISTICS : Age : Any age Sex : Female Menopausal status : Pre postmenopausal Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant No allergy sensitivity radiopharmaceutical patent blue V dye PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy Chemotherapy : No prior neoadjuvant chemotherapy Endocrine therapy : No prior endocrine therapy Radiotherapy : No prior neoadjuvant radiotherapy Surgery : No prior breast surgical biopsy axillary surgery</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>